Valneva Shares Surge as European Regulator Reviews Lyme Disease Vaccine
Valneva shares surged 30.3% to 3.20 euros on the SBF 120 index after the European Medicines Agency accepted its marketing authorization application for a Lyme disease vaccine. Developed alongside Pfizer, ... Read More